The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting

<table>The 50 mg/kg X3 Tandem Dose Wagner-Nelson Plot (presented as mean values).</table>

Journal of Drug Delivery

fig5

Figure 5

Figure 5: The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting 

Figure 5 | The Impact of Dosing Interval in a Novel Tandem  Oral Dosing Strategy: Enhancing the Exposure of Low  Solubility Drug Candidates in a Preclinical Setting 